01513nas a2200217   4500000000100000008004100001653003700042653001600079653001200095653002000107100001600127700001300143700001100156700001400167245004600181856007000227300001000297490000600307050001900313520096300332       2013                            d10aMultibacillary multidrug therapy10aElimination10aleprosy10aHistoid leprosy1 aDandekeri S1 aPinto HP1 aBhat R1 aSrinath M00aHistoid leprosy in the era of elimination  uhttp://www.mjmsr.net/temp/MullerJMedSciRes4129-1839203_050632.pdf  a29-310 v4  aDANDEKERI 20133 aHistoid leprosy is a variant of Lepromatous leprosy believed to occur due to a mutant strain of leprosy bacillus called as Histoid Bacillus. It was first described by Wade in 1960 in patients from Phillipines. It occurs in patients relapsing after Dapsone monotherapy, in the presence of Dapsone resistance or at times denovo, presenting with lesions mainly over bony prominences. Herein, we present a case of a 37 year old male who presented with skin coloured raised lesions mainly over the trunk, chest, neck and ears in contrast to its usual site of presentation, associated with tingling sensation over the hands and feet. A histopathological examination of the skin lesion was ordered which revealed sheets of histiocytes and lepra bacilli on hematoxylin and eosin and acid fast staining. On correlating the clinical and histopathological findings we came to a diagnosis of Histoid leprosy. The patient was promptly treated with MB-MDT and followed up.